Efficacy and Safety of Anti-vascular Endothelial Growth Factor (VEGF) Therapy With Intravitreal Ranibizumab (Lucentis) for Naive Retinal Vein Occlusion: 1-year Follow-up

How safe and effective is intravitreal ranibizumab in treating retinal vein occlusion?
The British Journal of Ophthalmology

Full Story →